HIV-1 subtype diversity in Minnesota

被引:31
作者
Sides, TL
Akinsete, O
Henry, K
Wotton, JT
Carr, PW
Bartkus, J
机构
[1] Minnesota Dept Hlth, Minneapolis, MN 55414 USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
关键词
D O I
10.1086/430322
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Genetic variation in human immunodeficiency virus (HIV)-1 poses significant public-health and clinical challenges. In North America, subtype B is most prevalent. HIV-1 subtyping is not integrated into routine HIV/acquired immunodeficiency syndrome surveillance in the United States. In 2003, the Minnesota Department of Health piloted HIV-1 subtyping with routine surveillance to describe the existence and variety of non-subtype B strains. Methods. Targeted HIV-1 subtype surveillance was conducted on 98 African-born HIV-infected patients. Sentinel subtype surveillance was conducted in a Minneapolis sexually transmitted disease clinic on 28 newly diagnosed non-African HIV-positive patients. Subtype determination was based on a partial sequence of the gp41 region of the HIV-1 env gene. Results. Subtyping was successful for 87 of 98 samples from African-born HIV-infected patients; 95% were non-B subtypes. The 7 subtypes observed were consistent with strains endemic in patients' birth regions. Subtyping was also completed for samples from 25 of 28 non-African-born patients; all were subtype B. Conclusions. Multiple HIV-1 subtypes are present in Minnesota. Our data suggest that most of the HIV cases in Minnesota among African-born patients are non-B subtypes. Population-based surveillance inclusive of groups at high risk for variant strains is needed to monitor the prevalence and variety of HIV subtypes in the United States.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 74 条
[61]  
Sullivan FS, 1997, JAMA-J AM MED ASSOC, V278, P292
[62]   Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States [J].
Sullivan, PS ;
Do, AN ;
Ellenberger, D ;
Pau, CP ;
Paul, S ;
Robbins, K ;
Kalish, M ;
Storck, C ;
Schable, CA ;
Wise, H ;
Tetteh, C ;
Jones, JL ;
McFarland, J ;
Yang, CF ;
Lal, RB ;
Ward, JW .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :463-469
[63]   The public health significance of HIV-1 subtypes [J].
Tatt, ID ;
Barlow, KL ;
Nicoll, A ;
Clewley, JP .
AIDS, 2001, 15 :S59-S71
[64]  
Telenti A, 2004, ANTIVIR THER, V9, P1
[65]   Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy [J].
Thomson, MM ;
Pérez-Alvarez, L ;
Nájera, R .
LANCET INFECTIOUS DISEASES, 2002, 2 (08) :461-471
[66]   Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into western countries [J].
Thomson, MM ;
Nájera, R .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (12) :1732-1737
[67]  
*US CENS BUR, US CENS 2000 DAT
[68]  
US Department Homeland Security, 2003, 2002 YB IMM STAT
[69]   Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel [J].
Wegner, SA ;
Brodine, SK ;
Mascola, JR ;
Tasker, SA ;
Shaffer, RA ;
Starkey, MJ ;
Barile, A ;
Martin, GJ ;
Aronson, N ;
Emmons, WW ;
Stephan, K ;
Bloor, S ;
Vingerhoets, J ;
Hertogs, K ;
Larder, B .
AIDS, 2000, 14 (08) :1009-1015
[70]  
WEGNER SA, 2000, 4 INT WORKSH HIV DRU, P136